Kestra Medical Technologies, Ltd. Common Stock (KMTS) - Total Liabilities
Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) has total liabilities worth $82.62 Million USD as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore KMTS cash flow metrics to assess how effectively this company generates cash.
Kestra Medical Technologies, Ltd. Common Stock - Total Liabilities Trend (2020–2025)
This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See Kestra Medical Technologies, Ltd. Common net assets for net asset value and shareholders' equity analysis.
Kestra Medical Technologies, Ltd. Common Stock Competitors by Total Liabilities
The table below lists competitors of Kestra Medical Technologies, Ltd. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ATAI Life Sciences NV
XETRA:9VC
|
Germany | €79.91 Million |
|
Birchcliff Energy Ltd.
TO:BIR
|
Canada | CA$1.21 Billion |
|
Equital
TA:EQTL
|
Israel | ILA12.68 Billion |
|
China Communications Services Corporation Limited
F:CMW
|
Germany | €90.60 Billion |
|
Distribution Solutions Group Inc
NASDAQ:DSGR
|
USA | $1.11 Billion |
|
SINOTRANS LTD H YC 1
F:SIY
|
Germany | €38.08 Billion |
|
Macquarie Technology Group Ltd
AU:MAQ
|
Australia | AU$292.18 Million |
|
Triumph Financial, Inc.
NASDAQ:TFIN
|
USA | $5.44 Billion |
Liability Composition Analysis (2020–2025)
This chart breaks down Kestra Medical Technologies, Ltd. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Kestra Medical Technologies, Ltd. Common market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kestra Medical Technologies, Ltd. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
The table below shows the annual total liabilities of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | $90.34 Million | -64.62% |
| 2024-04-30 | $255.33 Million | +63.43% |
| 2023-04-30 | $156.23 Million | +443.31% |
| 2021-04-30 | $28.76 Million | +616.04% |
| 2020-04-30 | $4.02 Million | -- |
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more